Skip to main content
. Author manuscript; available in PMC: 2010 Aug 15.
Published in final edited form as: Clin Cancer Res. 2009 Aug 11;15(16):5234–5239. doi: 10.1158/1078-0432.CCR-08-2953

Figure 1.

Figure 1

Restriction Fragment Length Polymorphism (RFLP) analysis of human neuroblastoma (NBL) cell lines and patient samples. RFLP analysis was used to identify the genotypes of the rs1800795 SNP (-174 IL-6 (G>C)) in (A) human NBL cell lines and (B) high risk NBL patient DNA samples, and in a similar fashion, the genotypes of the rs8192284 SNP (D358A IL-6R) in (C) human NBL cell lines and (D) high risk NBL patient DNA samples were also characterized. See Table 2 for full genotype analysis.